Evidence map›Paper›PMID 27796676›Full record

ArticleBiomedical microdevices2016

Microfluidic advances in phenotypic antibiotic susceptibility testing.

Jennifer Campbell, Christine McBeth, Maxim Kalashnikov, Anna K Boardman, Andre Sharon, Alexis F Sauer-Budge

Abstract read
In one paragraph

Article in Biomedical microdevices, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Review
  5. Modern Tools for Rapid Diagnostics of Antimicrobial Resistance.Frontiers in cellular and infection microbiology · 2020
    Review
  6. Article
  7. Rapid Susceptibility Testing Methods.Clinics in laboratory medicine · 2019
    Review
  8. Article
  9. Single-cell electro-phenotyping for rapid assessment ofSensors and actuators. B, Chemical · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer CampbellFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA.
Christine McBethFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA.
Maxim KalashnikovFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA.
Anna K BoardmanFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA.
Andre SharonFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA.
Alexis F Sauer-BudgeFraunhofer USA - Center for Manufacturing Innovation, Brookline, MA, 02446, USA. asauerbudge@fraunhofer.org.

Funding

Microfluidic platform for stress-induced rapid antibiotic susceptibility testingR01AI101446 · NIAID · FRAUNHOFER CENTER /MANUFACTURING INNOV · PI KALASHNIKOV, MAXIM · 2013 to 2017
$1.9M
NIAID NIH HHS R01 AI101446
6 · The paper itself

Abstract

A strong natural selection for microbial antibiotic resistance has resulted from the extensive use and misuse of antibiotics. Though multiple factors are responsible for this crisis, the most significant factor - widespread prescription of broad-spectrum antibiotics - is largely driven by the fact that the standard process for determining antibiotic susceptibility includes a 1-2-day culture period, resulting in 48-72 h from patient sample to final determination. Clearly, disruptive approaches, rather than small incremental gains, are needed to address this issue. The field of microfluidics promises several advantages over existing macro-scale methods, including: faster assays, increased multiplexing, smaller volumes, increased portability for potential point-of-care use, higher sensitivity, and rapid detection methods. This Perspective will cover the advances made in the field of microfluidic, phenotypic antibiotic susceptibility testing (AST) over the past two years. Sections are organized based on the functionality of the chip - from simple microscopy platforms, to gradient generators, to antibody-based capture devices. Microfluidic AST methods that monitor growth as well as those that are not based on growth are presented. Finally, we will give our perspective on the major hurdles still facing the field, including the need for rapid sample preparation and affordable detection technologies.

Indexed as

Lab-On-A-Chip DevicesPhenotypeAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialMicrobial Sensitivity TestsTime FactorsAnti-Bacterial AgentsAntibiotic susceptibility testingBacterial growthMicrofluidic methodologiesPoint-of-careRapid phenotypic screening

Identifiers

PMID27796676
PMCPMC5473355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.